Codexis (CDXS) Financials: Revenue & Earnings

CDXS price $1.28 +0.01 +0.39%

Ticker
CDXS
Price
$1.28
Change
+0.01 +0.39%
Market cap ?
$140.71M
Beta ?
2.55
Sector
Healthcare
Industry
Biotechnology

Fair value

CDXS fair value $1.67. Price $1.28. Price is 23% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 7.02M. Growth 4.97%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 109.51M. Net debt 22.41M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare CDXS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.10—18.72M
2026-08-11-0.13-0.1414.91M13.82M
2026-05-07-0.10-0.1115.25M14.53M
2026-03-110.110.0138.91M35.83M
2025-11-06-0.22-0.158.60M35.83M
2025-08-13-0.16-0.1715.33M19.48M
2025-05-14-0.25-0.207.54M9.66M
2025-02-27-0.13-0.0421.46M27.41M
2024-10-31-0.29-0.2512.83M27.41M
2024-08-08-0.32-0.267.98M7.82M
2024-05-02-0.16-0.1717.07M13.66M
2024-02-280.02-0.1626.56M19.90M
2023-11-02-0.50-0.329.28M10.03M
2023-08-03-0.17-0.2121.32M21.08M
2023-05-04-0.34-0.2912.98M14.09M
2023-02-23-0.19-0.2330.38M28.93M
2022-11-03-0.15-0.1834.47M30.94M
2022-08-04-0.04-0.1438.41M38.11M
2022-05-05-0.13-0.1835.34M28.59M
2022-02-24-0.16-0.1824.50M23.20M
2021-11-040.03-0.0936.77M28.50M
2021-08-05-0.07-0.1725.45M18.34M
2021-05-06-0.14-0.2018.03M23.44M
2021-02-25-0.06-0.1321.03M28.39M
2020-11-05-0.10-0.1618.39M20.22M
2020-08-06-0.11-0.2514.97M25.85M
2020-05-07-0.09-0.1314.67M16.93M
2020-02-270.020.0618.65M—
2019-11-050.04-0.0821.91M175.25M
2019-08-06-0.08-0.0612.32M10.27M
2019-05-06-0.05-0.0615.58M17.31M
2019-02-260.030.0216.07M48.20M
2018-11-08-0.04-0.0716.95M29.66M
2018-08-08-0.02-0.1213.54M23.21M
2018-05-10-0.05-0.0714.04M16.85M
2018-03-080.020.0521.72M54.31M
2017-11-09-0.21-0.169.98M8.08M
2017-08-09-0.13-0.1310.35M10.35M
2017-05-09-0.18-0.157.97M7.09M
2017-03-09-0.13-0.119.97M8.44M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-12Erbez GeorgiaSell6.33K$1.368.62K
2026-10-12MOORE ALISONSell6.33K$1.368.62K
2026-06-17PARKER H STEWARTBuy66.35K$2.48164.55K
2026-06-17Collins CynthiaBuy66.35K$2.48164.55K
2026-06-17Richards ChristosBuy66.35K$2.48164.55K
2026-06-17Smith David VBuy66.35K$2.48164.55K
2026-06-17Singhvi RahulBuy66.35K$2.48164.55K
2026-06-17Martinborough EstherBuy66.35K$2.48164.55K
2026-06-17DILLY STEPHEN GEORGEBuy66.35K$2.48164.55K
2026-06-17De Vre RaymondBuy66.35K$2.48164.55K
2026-06-11De Vre RaymondSell2.60K$2.376.17K
2026-02-24Lutz StefanSell5.86K$1.136.64K
2026-02-23Lutz StefanBuy316.10K$1.07338.23K
2026-02-23MOORE ALISONBuy993.00K$1.071.06M
2026-02-23Erbez GeorgiaBuy316.10K$1.07338.23K
2026-02-06Lutz StefanSell2.49K$1.313.26K
2026-02-06Erbez GeorgiaSell3.83K$1.315.00K
2026-02-06MOORE ALISONSell3.83K$1.315.00K
2026-01-07Lutz StefanSell4.68K$1.707.95K
2025-12-01Opaleye Management Inc.Sell245.00K$1.67408.54K
2025-12-01Opaleye Management Inc.Sell8.53K$1.6714.23K
2025-11-28Opaleye Management Inc.Sell105.00K$1.75183.75K
2025-11-28Opaleye Management Inc.Sell2.49K$1.754.36K
2025-11-26Opaleye Management Inc.Sell148.32K$1.74258.27K
2025-11-26Opaleye Management Inc.Buy148.32K$1.74258.27K
2025-11-26Opaleye Management Inc.Sell5.00K$1.748.71K
2025-11-21WOLF DENNIS PSell8.95K$1.5613.99K
2025-11-13MOORE ALISONBuy500.00K$1.63815.00K
2025-11-13MOORE ALISONBuy85.00K——
2025-11-12Opaleye Management Inc.Buy890.00K$1.941.72M
2025-11-12Opaleye Management Inc.Sell165.00K$1.96323.73K
2025-11-12Opaleye Management Inc.Sell27.46K$1.9453.19K
2025-11-11De Vre RaymondSell1.41K$1.742.46K
2025-11-11DILLY STEPHEN GEORGEBuy50.00K$1.8592.36K
2025-11-11Opaleye Management Inc.Sell535.00K$1.80962.68K
2025-11-11Opaleye Management Inc.Sell13.21K$1.8023.77K
2025-11-10Opaleye Management Inc.Sell205.00K$1.73355.61K
2025-11-10Opaleye Management Inc.Sell3.32K$1.735.76K
2025-11-07Opaleye Management Inc.Sell296.68K$1.70503.41K
2025-11-07Lutz StefanOther0——
2025-11-07Lutz StefanOther209.40K$3.05638.67K
2025-11-07Lutz StefanOther105.00K$4.37458.85K
2025-11-07Lutz StefanOther16.01K$26.16418.72K
2025-11-07Lutz StefanOther17.00K$19.39329.63K
2025-11-07Lutz StefanOther112.50K$5.44612.00K
2025-11-07Lutz StefanOther8.80K$11.79103.75K
2025-11-07Opaleye Management Inc.Buy296.68K$1.70503.41K
2025-11-07Opaleye Management Inc.Sell10.00K$1.7016.97K
2025-10-13MOORE ALISONSell6.24K$2.5115.63K
2025-10-13Erbez GeorgiaSell6.24K$2.5015.63K
2025-08-04Opaleye Management Inc.Buy780$2.832.21K
2025-07-31Opaleye Management Inc.Buy84.22K$2.68225.71K
2025-07-30Opaleye Management Inc.Buy1.58K$2.794.41K
2025-07-29Opaleye Management Inc.Buy8.42K$2.8223.75K
2025-07-18Opaleye Management Inc.Buy100.00K$2.82282.00K
2025-06-27Opaleye Management Inc.Buy100.00K$2.39239.00K
2025-06-16Opaleye Management Inc.Buy50.90K$2.24114.01K
2025-06-13Opaleye Management Inc.Buy99.10K$2.23221.00K
2025-06-12Opaleye Management Inc.Buy100.00K$2.25225.00K
2025-06-10WOLF DENNIS PBuy40.98K——
2025-06-10Smith David VBuy40.98K——
2025-06-10Singhvi RahulBuy40.98K——
2025-06-10Richards ChristosBuy40.98K——
2025-06-10PARKER H STEWARTBuy40.98K——
2025-06-10Martinborough EstherBuy40.98K——
2025-06-10De Vre RaymondBuy40.98K——
2025-06-10Collins CynthiaBuy40.98K——
2025-05-28Opaleye Management Inc.Buy5.00K$2.3611.80K
2025-05-23Opaleye Management Inc.Buy2.32M$2.365.48M
2025-05-01Opaleye Management Inc.Buy20.00K$2.3246.44K
2025-04-30Opaleye Management Inc.Buy25.00K$2.3157.66K
2025-04-25Opaleye Management Inc.Buy25.00K$2.2455.91K
2025-04-17Opaleye Management Inc.Buy45.00K$2.0994.16K
2025-04-16Opaleye Management Inc.Buy70.00K$2.13148.89K
2025-04-15Opaleye Management Inc.Buy25.00K$2.2355.72K
2025-04-08Opaleye Management Inc.Buy100.00K$1.98198.38K
2025-04-03Opaleye Management Inc.Buy75.00K$2.30172.74K
2025-04-02Opaleye Management Inc.Buy5.00K$2.4612.28K
2025-04-01Opaleye Management Inc.Buy35.00K$2.4886.77K
2025-03-28Collins CynthiaBuy71.17K——
2025-03-28Collins CynthiaOther0——
2025-03-21Opaleye Management Inc.Buy92.92K$2.54236.27K
2025-03-20Opaleye Management Inc.Buy7$2.5418
2025-03-13Opaleye Management Inc.Buy85.00K$2.54216.16K
2025-03-06Opaleye Management Inc.Buy100.00K$2.61261.35K
2025-03-05Opaleye Management Inc.Buy10.00K$2.6926.88K
2025-03-04Opaleye Management Inc.Buy55.00K$2.64145.40K
2025-03-03Opaleye Management Inc.Buy47.35K$2.81133.17K
2025-02-28Opaleye Management Inc.Buy147.65K$2.99441.18K
2025-02-12Opaleye Management Inc.Buy15.00K$4.0059.93K
2025-02-11Opaleye Management Inc.Buy12.50K$4.1151.40K
2025-02-10Opaleye Management Inc.Buy22.50K$4.1894.15K
2025-02-05Norrett KevinBuy26.88K——
2025-02-05Norrett KevinBuy161.25K$4.37704.66K
2025-02-05MOORE ALISONBuy26.88K——
2025-02-05MOORE ALISONBuy161.25K$4.37704.66K
2025-02-05Erbez GeorgiaBuy161.25K$4.37704.66K
2025-02-05Erbez GeorgiaBuy26.88K——
2025-02-05DILLY STEPHEN GEORGEBuy88.75K——
2025-02-05DILLY STEPHEN GEORGEBuy532.50K$4.372.33M

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 151, holders +16 vs prior quarter. Ownership 71.51%.

HolderSharesChangeChange %Value
BLACKROCK, INC.7.28M255.58K+3.64%16.46M
OPALEYE MANAGEMENT INC.6.79M00.00%15.33M
ABERDEEN GROUP PLC6.77M-1.91M-22.01%15.30M
MILLENNIUM MANAGEMENT LLC5.55M1.55M+38.79%12.54M
TELEMARK ASSET MANAGEMENT, LLC3.85M00.00%8.69M
AMERIPRISE FINANCIAL INC3.81M408.94K+12.03%8.61M
NANTAHALA CAPITAL MANAGEMENT, LLC3.62M-500.00K-12.13%8.19M
VANGUARD CAPITAL MANAGEMENT LLC3.62M-51.40K-1.40%8.17M
GEODE CAPITAL MANAGEMENT, LLC2.16M277.04K+14.69%4.89M
STATE STREET CORP1.76M89.86K+5.39%3.97M
D. E. SHAW & CO., INC.1.34M362.17K+36.96%3.03M
JACOBS LEVY EQUITY MANAGEMENT, INC1.33M242.18K+22.26%3.01M
VANGUARD PORTFOLIO MANAGEMENT LLC1.31M427.83K+48.65%2.95M
ASSENAGON ASSET MANAGEMENT S.A.1.28M527.04K+70.16%2.89M
AQR CAPITAL MANAGEMENT LLC845.43K236.83K+38.91%1.91M
TWO SIGMA INVESTMENTS, LP696.60K454.64K+187.90%1.57M
NORTHERN TRUST CORP682.94K25.80K+3.93%1.54M
FRANKLIN TEMPLETON INC678.64K-9.57K-1.39%1.53M
MORGAN STANLEY649.17K176.33K+37.29%1.47M
VANGUARD FIDUCIARY TRUST CO581.06K30.05K+5.45%1.31M
MAN GROUP PLC565.59K565.59KNew1.28M
POST RESCH TALLON GROUP INC.563.48K-8.00K-1.40%1.27M
PERKINS CAPITAL MANAGEMENT INC526.10K-1.40K-0.27%1.19M
FMR LLC478.48K65.89K+15.97%1.08M
GOLDMAN SACHS GROUP INC434.92K-389.95K-47.27%982.93K

Earnings and financials

Codexis, Inc. (CDXS) trades at $1.28, with a market cap of $140.71M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Codexis (CDXS) Financials: Revenue & Earnings

CDXS$1.28+0.01 +0.39%

$140.71M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History